medicines


Data exclusivity still key hurdle to India-EU FTA
Despite all official assurances, the path towards a free trade agreement between India and the European Union this year remains ambiguous, as both sides are unwilling to relax their stand on the biggest stumbling block — the issue of “data exclusivity”.
TPPA: Challenges for Australian health and medicine policies
Of particular concern is that proposed TPPA multilateral investor–state dispute settlement procedures would allow US corporations (as well as those of other TPPA nations) to obtain damages against Australian governments through international arbitral proceedings if their investments are impeded by Australian public health and environment protection legislation.
Public health related TRIPS-plus provisions in bilateral trade agreements: A policy guide for negotiators and implementers in the WHO Eastern Mediterranean region
The main focus of this comprehensive policy guide—the first of its kind solely dedicated to the region—is to analyze the effect of bilateral trade agreements on public health regimes and access to medicines in the countries of the Eastern Mediterranean Region.
Drug patents remain a major FTA battleground
Drug patent restrictions by the United States and the European Union in trade negotiations with emerging countries will harm the Thai pharmaceutical industry and affect local patients, say researchers.
Rally protests EU-India trade pact which may cause end of generic drugs
Marking strong protest against the proposed signing of the European Union-India Free Trade Agreement on IP Provision, a mass protest rally was taken out today jointly by the Centre for Social Development in collaboration with organisation working on drugs and HIV/AIDS, North East Diaglogue Forum, Women Action for Development and Bosco Mangal, Chingmeirong Don Bosco Society, Imphal.
Leaked NZ paper challenges past US FTA models in TPP negotiations
A confidential Trans-Pacific Partnership Agreement negotiating paper authored by New Zealand suggests that the trade pact’s patent and copyright provisions be no more stringent than existing global standards
EU trade talks may deal blow to Aids fight
Fears have been raised that cheap life-saving anti-retroviral drugs may no longer be available in Kenya if a trade agreement between the EU and India is concluded.
FTA pact's product list under attack
The government is coming under increasing attack from activists for pushing ahead with EU-Thailand free trade agreement talks which include alcohol, tobacco and medicines.
Europe attacking access to affordable generic drugs
The EU claims data exclusivity is required under international law. It is not. It also claims that there will be no harm to access to medicines. But other countries have learned the hard way how harmful it can be.
Afrique : L’accord UE-Inde pourrait menacer l’accès à des médicaments VIH essentiels
Alors que des responsables indiens et européens se rencontrent à Bruxelles pour mettre au point les détails d’un accord de libre-échange, des activistes de la société civile s’inquiètent que l’accord puisse déboucher sur une protection renforcée de la propriété intellectuelle qui pourrait réduire l’accès aux médicaments génériques indiens bon marché.